| Overview of hepatitis B viral replication and genetic variability S Tong, P Revill Journal of hepatology 64 (1), S4-S16, 2016 | 496 | 2016 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 493 | 2019 |
| Design and application of two novel degenerate primer pairs for the detection and complete genomic characterization of potyviruses C Ha, S Coombs, PA Revill, RM Harding, M Vu, JL Dale Archives of virology 153, 25-36, 2008 | 285 | 2008 |
| Taxonomy of the order Mononegavirales: update 2017 GK Amarasinghe, Y Bào, CF Basler, S Bavari, M Beer, N Bejerman, ... Archives of virology 162, 2493-2504, 2017 | 271 | 2017 |
| HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B BK Kim, PA Revill, SH Ahn Antiviral therapy 16 (8), 1169-1186, 2011 | 208 | 2011 |
| Global strategies are required to cure and eliminate HBV infection P Revill, B Testoni, S Locarnini, F Zoulim Nature reviews Gastroenterology & hepatology 13 (4), 239-248, 2016 | 190 | 2016 |
| On the evolution and molecular epidemiology of the potyvirus Papaya ringspot virus MF Bateson, RE Lines, P Revill, W Chaleeprom, CV Ha, AJ Gibbs, ... Journal of General Virology 83 (10), 2575-2585, 2002 | 179 | 2002 |
| The evolution and clinical impact of hepatitis B virus genome diversity PA Revill, T Tu, HJ Netter, LKW Yuen, SA Locarnini, M Littlejohn Nature Reviews Gastroenterology & Hepatology 17 (10), 618-634, 2020 | 162 | 2020 |
| 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B-Report from the 2019 EASL-AASLD HBV … T Berg, M Brunetto, S Buchholz, M Buti, C Hly, K Chang, M Dandri, ... Journal of Hepatology, 2019 | 161 | 2019 |
| Molecular characterization of begomoviruses and DNA satellites from Vietnam: additional evidence that the New World geminiviruses were present in the Old World prior to … C Ha, S Coombs, P Revill, R Harding, M Vu, J Dale Journal of General Virology 89 (1), 312-326, 2008 | 160 | 2008 |
| A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook A Kramvis, KM Chang, M Dandri, P Farci, D Glebe, J Hu, HLA Janssen, ... Nature Reviews Gastroenterology & Hepatology 19 (11), 727-745, 2022 | 132 | 2022 |
| Insights from deep sequencing of the HBV genome—unique, tiny, and misunderstood AL McNaughton, V D’Arienzo, MA Ansari, SF Lumley, M Littlejohn, ... Gastroenterology 156 (2), 384-399, 2019 | 127 | 2019 |
| Sequence diversity of South Pacific isolates of Taro bacilliform virus and the development of a PCR-based diagnostic test IC Yang, GJ Hafner, PA Revill, JL Dale, RM Harding Archives of Virology 148, 1957-1968, 2003 | 121 | 2003 |
| Identification and sequence analysis of potyviruses infecting crops in Vietnam C Ha, P Revill, RM Harding, M Vu, JL Dale Archives of virology 153, 45-60, 2008 | 114 | 2008 |
| Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus G Ebert, S Preston, C Allison, J Cooney, JG Toe, MD Stutz, S Ojaimi, ... Proceedings of the National Academy of Sciences 112 (18), 5797-5802, 2015 | 113 | 2015 |
| A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics CP Desmond, A Bartholomeusz, S Gaudieri, PA Revill, SR Lewin Antiviral therapy 13 (2), 161-176, 2008 | 111 | 2008 |
| Characterization of the innate immune signalling pathways in hepatocyte cell lines S Preiss, A Thompson, X Chen, S Rodgers, V Markovska, P Desmond, ... Journal of viral hepatitis 15 (12), 888-900, 2008 | 97 | 2008 |
| A research agenda for curing chronic hepatitis B virus infection H Alter, T Block, N Brown, A Brownstein, C Brosgart, KM Chang, PJ Chen, ... Hepatology 67 (3), 1127-1131, 2018 | 91 | 2018 |
| Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma J Bayliss, L Lim, AJV Thompson, P Desmond, P Angus, S Locarnini, ... Journal of hepatology 59 (5), 1022-1028, 2013 | 87 | 2013 |
| Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus GV Matthews, EC Seaberg, A Avihingsanon, S Bowden, GJ Dore, ... Clinical Infectious Diseases 56 (9), e87-e94, 2013 | 84 | 2013 |
